Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 3/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.64 |
| ▸ | HPGD | P15428 | 2/20 | 0.64 |
| ▸ | RECQL | P46063 | 1/20 | 0.53 |
| ▸ | ESR1 | P03372 | 3/20 | 0.48 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | PKM | P14618 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29624740 | 1.00 | RAB9A (1.00) | RAB9AKDM4EALDH1A1HPGDRECQL | |
| SCHEMBL5473377 | 0.85 | RAB9A (0.73) | RAB9AKDM4EALDH1A1HPGDRECQL | |
| SCHEMBL13547667 | 0.84 | RAB9A (0.71) | RAB9AKDM4EALDH1A1HPGDRECQL | |
| SCHEMBL5468221 | 0.83 | RAB9A (0.71) | RAB9AKDM4EALDH1A1HPGDRECQL | |
| SCHEMBL13260865 | 0.82 | RAB9A (0.68) | RAB9AKDM4EALDH1A1HPGDRECQL | |
| SCHEMBL13547663 | 0.82 | RAB9A (0.69) | RAB9AKDM4EALDH1A1HPGDESR1 | |
| SCHEMBL13547606 | 0.81 | RAB9A (0.68) | RAB9AKDM4EALDH1A1HPGDRECQL | |
| SCHEMBL14128970 | 0.81 | RAB9A (0.68) | RAB9AKDM4EALDH1A1HPGDRECQL | |
| SCHEMBL13936053 | 0.81 | RAB9A (0.68) | RAB9AKDM4EALDH1A1HPGDRECQL | |
| SCHEMBL22955863 | 0.80 | RAB9A (0.67) | RAB9AKDM4EALDH1A1HPGDNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0968254-B1 | FLUORESCENT MATERIALS AND THEIR USE | CIBA SC HOLDING AG (CH) | 2004-09-15 | — | — | EP | claimed |
| US-20030023097-A1 | Fluorescent materials and their use | OTANI JUNJI (JP) | 2003-01-30 | — | — | US | claimed |
| EP-0963425-B1 | FLUORESCENT COMPOSITIONS AND THEIR USE | CIBA SC HOLDING AG (CH) | 2002-04-24 | — | — | EP | claimed |
| EP-0968253-B1 | FLUORESCENT HOST-GUEST-SYSTEM | CIBA SC HOLDING AG (CH) | 2002-02-13 | — | — | EP | claimed |
| EP-0963426-B1 | FLUORESCENT CHROMOPHORE, COVALENTLY LINKED TO AN ORGANIC SUPPORT MATERIAL | CIBA SC HOLDING AG (CH) | 2001-10-24 | — | — | EP | claimed |
| US-20010016269-A1 | FLUORESCENT MATERIALS AND THEIR USE | CIBA SPECIALTY CHEMICALS CORP. | 2001-08-23 | — | — | US | claimed |
| US-6146809-A | FLUORESCENCE EMISSION SPECTRUM OF THE HOST CHROMOPHORE OVERLAPS WITH THE ABSORPTION SPECTRUM OF THE GUEST CHROMOPHORE | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2000-11-14 | — | — | US | claimed |
| US-6103446-A | CHROMOPHORES OF BENZO(4,5)IMIDAZO(2,1-A)ISOINDOL-11-ONES COVALENTLY LINKED TO ACRYLATE POLYMERS; RELIEF IMAGES; SOLID-STATE FLUORESCENCE WITH A HIGH EMISSION INTENSITY | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2000-08-15 | — | — | US | claimed |
| EP-0968254-A1 | FLUORESCENT MATERIALS AND THEIR USE | Ciba SC Holding AG (CH) | 2000-01-05 | — | — | EP | claimed |
| WO-1998033862-A1 | FLUORESCENT MATERIALS AND THEIR USE | CIBA SPECIALITY CHEMICALS HOLDING INC. (CH) | 1998-08-06 | — | — | WO | claimed |
| EP-2362731-B1 | NOVEL CYCLIC BENZIMIDAZOLE DERIVATIVES USEFUL ANTI-DIABETIC AGENTS | MERCK SHARP & DOHME (US) | 2016-04-06 | — | — | EP | disclosed |
| EP-2352374-B1 | NOVEL CYCLIC BENZIMIDAZOLE DERIVATIVES USEFUL ANTI-DIABETIC AGENTS | MERCK SHARP & DOHME (US) | 2014-09-24 | — | — | EP | disclosed |
| US-8563746-B2 | Cyclic benzimidazole derivatives useful as anti-diabetic agents | MERCK SHARP & DOHME CORP (US) | 2013-10-22 | — | — | US | disclosed |
| US-8329914-B2 | Cyclic benzimidazole derivatives useful as anti-diabetic agents | MERCK SHARP & DOHME CORP (US) | 2012-12-11 | — | — | US | disclosed |
| CN-102271511-A | Novel cyclic benzimidazole derivatives useful anti-diabetic agents | — | 2011-12-07 | — | — | CN | disclosed |
| WO-1998033862-A1 | FLUORESCENT MATERIALS AND THEIR USE | CIBA SPECIALITY CHEMICALS HOLDING INC. (CH) | 1998-08-06 | — | — | WO | disclosed |
| WO-1998033862-A1 | FLUORESCENT MATERIALS AND THEIR USE | CIBA SPECIALITY CHEMICALS HOLDING INC. (CH) | 1998-08-06 | — | — | WO | disclosed |
| WO-1998033865-A1 | FLUORESCENT CHROMOPHORE, COVALENTLY LINKED TO AN ORGANIC SUPPORT MATERIAL | CIBA SPECIALTY CHEMICALS HOLDING, INC. (CH) | 1998-08-06 | — | — | WO | disclosed |
| WO-1998033864-A1 | FLUORESCENT COMPOSITIONS AND THEIR USE | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 1998-08-06 | — | — | WO | disclosed |
| US-4623379-A | Plant growth and development modification using 2-(2-oxycarbonylphenyl)benzimidazole derivatives | FMC CORPORATION (US) | 1986-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030023097-A1 | Fluorescent materials and their use | VCL, VIM, COL14A1 | RAB9A 1669/4885KDM4E 4210/4885ALDH1A1 788/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.